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Summary.-When symmetrical 1,2 dimethylhydrazine was administered to rats by
weekly s.c. injection, 37% of the animals had developed small intestinal carcinomas
after 21-27 weeks. These lesions were largely localized to duodenum and upper
jejunum. At the same time there was a diffuse crypt hyperplasia in thejejunum which
affected all the treated animals, not just those with neoplasms. This marked hyper-
plasia was preceded by a modest sustained crypt elongation which was seen soon
after DMH injections began.
In these hyperplastic jejunal crypts the absolute size of the proliferative compart-
ment was increased, but the growth fraction calculated from labelling studies
appeared to fall, probably by reduction in relative size of the proliferating population
within the proliferative compartment.
No convincing alteration in actual cell-cycle time was observed in the abnormal
crypts. There was a slight (25%) increase in cell-production rate in the abnormal
crypts.
SYMMETRICAL 1,2-dimethylhydrazine
(DMH) is a potent chemical carcinogen
when administered to a variety ofrodents.
It is probably best known for its ability to
induce colonic neoplasms, both in rats
(Druckrey et al., 1967) and in mice
(Wiebecke et at., 1969; Pegg and Hawks,
1971). Whilst injection ofDMH appears to
induce only colonic neoplasms in most
strains of mice, it induces in rats a variety
ofotherneoplasms as well. These occur less
frequentlythanthe colonic neoplasms, and
include occasional hepatic and renal
tumours (Druckrey, 1970) and tumours of
the ear canal (Reddy et al., 1975). Curious
lesions of the stomach and biliary tree
were described by Martin et at. (1973).
All these authors describe the additional
occurrence of small-intestinal neoplasms
in treated rats. The lesions are often
malignant, and are usually located in the
duodenum or the proximal part of the
jejunum.
Apparently preneoplastic, or paranco-
plastic, abnormalities have been described
by several authors in the intestinal mucosa
ofDMH-treated animals. In the colon, 3H-
thymidine labelling is seen higher up the
crypt in DMH-treated mice than in
control mice (Deschner, 1974; Lipkin,
1974). In rats, there is a generalized in-
crease in the height of the colonic crypts
of treated animals (Wiebecke et al., 1973)
and in the circumference of the crypts
(Tutton and Barkla, 1976). Such changes
in the small-intestinal mucosa of DMH-
treated animals have been less well
recognized, although "mucosal hyper-
plasias" have been described (WViebecke
et al., 1973).
In the present study DMH was ad-
ministered to rats and changes in the
crypts of the jejunal mucosa were moni-
tored over the experimental period up to
the development of frank neoplasia.
Cytokinetic studies using tritiated thymi-
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dine (3H-TdR) and vincristine have been
carried out in an attempt to define some
of the kinetic characteristics of the
morphologically abnormal but non-neo-
plastic mucosae of treated animals.
The data are compared with control data,
and with normal values for animals from
our colony.
MATERIALS AND METHODS
Animals and DMH-treatment regime.-
Randomly bred female albino Wistar rats
were used. At the beginning of DMH treat-
ment the animals were 12-16 weeks of age
and weighed 250-300 g. They were fed on
standard rat cake (N.E. Farmers) and water
ad libitum.
Symmetrical dimethylhydrazine dihydro-
chloride (Aldrich Chemical Co.) was ad-
ministered by weekly s.c. injection at a dose
of 15 mg (base)/kg body wt. The chemical
was dissolved at a concentration of 1-66 g (of
dihydrochloride) per 100 ml in normal saline
containing 1-500 of EDTA added as a
stabilizing agent. The solution was brought
to a pH of 6-4 by the addition of N NaOH. It
was freshly prepared each week. An interval
ofat least 1 week was observed between the
final DMH injection and the killing of the
animals, in order to avoid distortions arising
from any acute effects of DMH on cell
proliferation.
Crypt analysis during DMH treatment.-At
various times after the start of DMH treat-
ment (ranging between 4 and 27 weeks) small
groups of 2 or 3 animals were killed by
cervical dislocation. One hour before this the
animals were given 3H-TdR (Radiochemical
Centre, Amersham), by i.p. injection at a dose
of 0-5 ,uCi/g body wt; the specific activity of
the 3H-TdR was 5 Ci/m mol. A full necropsy
was performed on each animal and particular
attention was paid to the appearances of the
small intestine and colon. These viscera were
fixed for 6 h in Carnoy's fixative, and
samples of small intestine were taken from a
site just distal to the ligament of Treitz and
from all small-intestinal tumours.
These transverse sections were processed
through to paraffin wax and serial 3 ,um
sections were prepared and stained with
haematoxylin and eosin and periodic acid/
Schiff with and without amylase. Micro-
autoradiographs were also prepared in the
usual way (Al-Dewachi et al., 1974). All
neoplasms were categorized histologically
into subgroups (see Results section). In the
sections of jejunum, the "left" sides of 30
axially sectioned crypts wAere analysed per
animal. The cell positions of labelled nuclei
and of metaphase mitotic figures were
recorded in terms of serial position counting
upwards from Position 1 in the base of the
crypt, together with the heights of individual
crypts in cells (Cairnie, Lamerton and Steel,
1965); a cell was regarded as labelled if 5 or
more grains were located over the nucleus
(Wright, 1971). In each animal the data were
projected on to a standard crypt the height
of which was the mean crypt height of the
animal concerned. The previously described
modification (Wright, Morley and Appleton,
1972) of the method of Cairnie and Bentley
(1967) to compensate for variation in crypt
height was used to produce labelling and
mitotic-index distribution diagrams. The
circumference of crypts was measured by
counting the number of cells appearing in
transverse sections of crypts containing
metaphases: "crypt column count". The
mean of50 such columncountswascalculated,
in each of 4 treated animals, and the inter-
animal mean was determined.
All the animals in this experiinent were
killed at the same time ofday (15.00 hours) in
order to avoid any artefacts arising from
diurnal variation (Sigdestad, Bauman and
Lesher, 1969; Al-Dewachi et al., 1976).
Frequency oflabelled mitoses (FLM) studies.
-Thirty rats which had received 24 weekly
injections of DMH were given 3H-TdR at a
dose of 0-5 ,uCi/g body wt by i.p. injection at
0900 h. The animals were then killed serially
at hourly intervals up to 12 h and then at
2-hourly intervals up to 50 h. Histological
sections and autoradiographs were prepared
as before from small-intestinal tumours and
from macroscopically normal jejunum just
distal to the ligament of Treitz. In the
microautoradiographs of the jejunum, the
crypt was divided for the purpose of analysis
into cell-position groups, each group consist-
ing of 4 cell positions. The lowest group
consisted of Cell Positions 1-4, the second
group Positions 5-8, and so on up the crypt.
In each section a minimum of 20 mitotic
figures wias counted in each cell-position
group, and the proportion of labelled mitoses
was determined. In this way for each of the
cell-position groups FLM curves were con-
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str-ucted, and the data were analysed by the
metlhod of Gilbert (1972).
V;inocristinte stuidies. Eighteen animals which
had received 24 w^eekly injections of DM1H
w<ere given vincristine sulphate (Oncovin, Eli
Lilly) by i.p. injection at a dosage of 1 mg/kg
body wt at 09.0()hours. rhe animals were
then killed serially in groups of 3 at 20 min
intervals up to 120 min after injection.
Sections fromn upperjejunum andanytumours
wN-ere taken and processed as before. Using
serial histological sections from the jejunum,
the left sides" of 100 axially sectioned
crypts were analysed in each animal. The cell
position of arrested metaphases was recorded,
as well as total crypt height. Adequacy of
metaphase arrest was confirmed by the
absence of' any post-metaphase mitotic
figures. As before, the data were projected on
to a standard crypt, the height of which was
the mean crypt height for all the animals in
the vincristine group. This standard crypt
was divided into cell position groups as
described for the FLM experiment, and for
each of these cell-position groups the cumu-
lative mitotic index was plotted against time
after vincristine.
From an analysis of 200( cr'oss sections of
jejunal crypts containing metaphases (50
from each of 4 animals) a correction factor
w%as calculated to comnpensate for the over-
estimation of mitotic index due to migration
of mitotic figures into the lumen of the crypt
(Taninock, 1967).
RESULTS AND INTERP'RIETATION
Acoplasm1s
In animnals killedl after 21-27 weeks of
)MII injections, the inicidence of colonic
neoplasms is virtually 100%. Most of the
animals have several colonic tumouirs, and
both benign and malignant types are
represented.
By contrast the incidence of small-
initestinal neoplasms is muchl lower: only
33 animals out of an initial series of 90
(i.e. 37% ) developed small intestinal
ttumours. The longer the duration of DMH
treatment the larger is the proportion of
animals developing small-intestinal tum-
ours. Again, in contrast to the large-bowel
neoplasms, which are almost invariably
miultiple, the small-intestinal tumours are
f'requently solitary: onlv 4/33 affected
animals manifested mnultiple tumours of
the small bowel. Most of the small
intestinal tumnours (33/39) were situated
within 40 mm of the pylorus, either in the
most proximal part of the jejunum or in
the distal duodenum. Animals with tum-
ours in the distal jejunum or ileum had co-
existent tumours in the upper small bowel.
The reason for this curious localization of
neoplasms in the upper small bowel
appears to be that DM1H is altered in the
liver and secreted into the bile (Pozharisski
et al., 1975): thus the uppermost portion
ofthesmall bowelis exposed moreintensely
than the more distal portions to the
carcinogenic stimulus.
Grossly, the small-bowel tumours are
either ulcerated plaque-like lesions, or
pearlv, partly cystic, tumour nodules
which grow through the muscular wall of
the bowel. Histologically all the tumours
are carcinomas. Four-fifths of the lesions
have a tubulopapillary structure and,
while invasion of the museularis propria
is a comnmon feature, some of these lesions
appear to be limited to mutcosa and sub-
mucosa. Some ofthe tumours show forma-
tion of large central cysts, and most of the
larger tumours have metastasized, at least
as far as the regional lymph nodes. A
smaller proportion of tumours (20°/) are
poorly differentiated mucin-secreting,
adenocarcinomas, showing a trabecular or
acinar pattern, or a signet ring appear-
ance.
Crypt hyperplasia
In occasional sectionis, examples are
seen of gross atypia affecting one or two or
a small group of crypt/villus units: w%e
consider that these lesions represent
established neoplasia. Quite different from
these changes is the general and striking
elongation of the intestinal crypts seen in
animals after 24 weeks and more of DMH
treatment (Fig. la and b). This remarkable
crypt hyperplasia is seen both in animals
bearing small-intestinal tumours, and in
the much larger proportion of animals not
so affected. In tumour-bearing animals,
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FIG. 1. (a) Normal rat jejunal mucosa in a cross section of bowel. (b) The hyperplastic mucosa of an
animal treated with DMH for 24 weeks. H. and E. x 125.
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crypt hyperplasia is noted at sites remote
from the tumours, and does not appear to
be simply a reaction to the presence of a
neoplasm.
Fig. 2 shows mean crypt height (in cells)
plotted against the duration of DMH
treatment in weeks. The mean crypt
height of control animals is 33-7 cells, and
this value is shown in the figure. Mean
crypt heights of individual experimental
animals are shown as dots, and the error
bars represent + s.e. mean. It can be seen
that very soon after initiation of DM1H
treatment there is a modest sustained
increase in the mean heights of crypts to
36-40 cells. Synchronously with the ap-
pearance of the first neoplasms at about
24 weeks of treatment, there is a further
dramatic increase in mean crypt height,
with individual means varying between 43
and 63 cells. This striking hyperplasia
occurs in the absence of any features of
atypia, and is generalized. Though the
crypts may be virtually doubled in length,
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their circumference remains unaltered, the
mean column count of treated animals
(22-8 cells) not differing significantly from
that of control animals (22.3 cells).
3H-TdR labelling
In control animals killed 1 h after
injection of 3H-TdR, the crude whole-
crypt labelling index (Is) is 26.3%. In Fig.
3 whole-crypt Is is plotted against the
duration of DMH treatment in weeks.
Although values are probably slightly
higher than the control level, there is no
significant change apparent in these ani-
mals over the experimental period.
Fig. 4 shows the distribution oflabelling
activity within the small-intestinal crypts
of one of the animals treated for 27 weeks
with DMH. The niean Is of each cell
position has been plotted against cell-
position number, and the curve has been
fitted by eye. The shaded areaindicatesthe
9500 confidence limits of the labelling-
index distribution curve of the control
group ofanimals. In the treated animal the
mean crypt height is 57 cells, as opposed to
34 in the control group. In general, the
shape of the curve is similar, with low
labelling indices in the basal cell positions,
and higher values further up the crypt,
declining to zero towards the top of the
crypt. Several major differences are appar-
ent, however: peak labelling index is much
higher (around 70%o as opposed to 48%
in the control animals) and labelling
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Fiet. 2. Mean crypt height (in cells) plotte(d
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Cellpeetionnumbr
Fic(. 4. The labelling-in(lex dlistribution
cutrve of one of the animals treatedl for 27
weeks with DM11, with the confidlence
limits of the control grouip superimposed.
activity is seen much further up the crypt,
in absolute thoug,h not in relative terms.
FLM experiment
Examples of the curves fitted by the
Gilbert programme are shown in Fig. 5.
Fig. 5a refers to Cell-position Group 1-4,
and 5b refers to 9-12. Fig. 5c represents
the pooled whole-crypt data. Table I sum-
marizes the estimates of duration of the
cell cycle (Tc) and the DNA-synthetic
phase (ts) in DMH-treated animals and in
normal animals from the same colony
(Al-Dewachi et al., 1974).
The values of Tc in the proliferative
compartment are virtually the same as in
the normal animals. The pattern of rela-
tively prolonged Tc in the basal cell-
position groups is retained, although in
Group 1-4 there may have been absolute
shortening of the duration of Tc. It is
difficult to be certain of this, since the
standard errors generated by the Gilbert
programme are almost certainly too small
in this situation. For the most part, ts
appears to be only slightly prolonged by
comparison with normal animals.
From labelling index data and the FLM
curve, some estimate of the proliferating
proportion, i.e. the growth fraction (Ip),
can be obtained. Cleaver (1967) proposed
that the cell position with 500/ ofthe peak
labelling index on the descending limb of
the distribution curve of the labelling
index, when compared with the total
length of the crypt, gave some estimate of
Ip. In the control group (see Fig. 4) a value
of Ip calculated by this method is 0 59.
This coincides very closely with an
estimate of 0 61 obtained by Wright and
his co-workers (1975). In the DMH-
treated animals lp calculated by this
method is found to be only slightly lower
than these normal values. In the curve
illustrated in Fig. 4, for example, lp is
0-56. Other animals killed at 27 weeks of
treatment show lp values of 0-56 and 0 55.
Although there is an increase in the size of
the proliferative compartment, there is
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TABLE I.-Summary ofEstimates ofT, (cell-cycle time) and ts (length ofSphase) Derived
from Computer Analysis of FLM Curves in Normal and DMH-treated Rats, Together
with Standard Errors
DMH-treated Control
Tc ts Tc ts
12-111-4
13-4±0-3
12 7±0 2
10 6+0 2
10 9±0 1
10 3±0 1
10 7±0 2
7 4+0 9
77±02
67±0 2
6-6±0-2
6-0±0-3
10 9±0 2 6 9±0 1
15 5±0 2
12 3±0 1
112±0 1
10-8± 0-
11 0±0 2
10 7±0 1
113±0-1
8-6±0 1
7 1±001
6 4±0 1
5-9±0-1
5-9±0-1
6*0±0*1
6-5±01
therefore a suggestion that the growth
fraction falls. A further method ofcalculat-
ing Ip is from the relationship:
Ip Is obs/Is exp
where Is obs is the observed value for the
labelling index, and Is exp a theoretical
value derived from the cell-cycle para-
meters and the age distribution. The cell-
cycle parameters have been calculated
from the FLM curve. Using the data of
Wright et al. (1975) and assuming an
exponential age distribution, the estimate
for lp in normal animals is 0-67. In the
DMH-treated animals this method gives
estimates of Ip in the 27-week survivors of
0-48, 0-48 and 0-52. These figures are
slightly lower than those derived from the
labelling index distribution curves.
Vincristine study
Examples of the graphs of cumulative
mitotic index against time are shown in
Fig. 6: a refers to cell-position Group 1-4,
b to Cell-position Group 9-12, while c is the
pooled whole-crypt data. The lines have
been fitted by least squares, and an
exponential age distribution has been
assumed; for comparison, the data of
Wright (1974) have also been analysed on
this assumption.
The correction factor to compensate for
migration of metaphases towards the
centre of the crypt (Tannock, 1967) was
measured in 200 crypt cross-sections, and
found to have a mean of 062. This is the
same as that obtained by Wright (1974) in
the normal rat.
In Table II the potential population-
doubling times, also referred to as appar-
ent cell-cycle times (Tc(a)), of DMH-
treated animals are compared with the
means calculated for normal rats. Tan-
nock's factor has been taken into account,
but no modifications have been made
because of changes in the growth frac-
tion. There is a common pattern of
relatively long potential population-
doubling times in the basal cells, with
shorter T,(a) in the cell-position groups in
the proliferative compartment. Higher up
the crypt, Tc(a) again becomes prolonged
owing to the fall in growth fraction. Even
with the imprecision ofthe stathmokinetic
method, it is apparent that in all the cell-
position groups within the proliferative
compartment, Tc(a) of treated animals is
prolonged when compared with normal.
Also, Tc(a) of the whole crypt is prolonged
in the treated animals when compared
with normals.
This prolongation of Tc(a) in DMH-
treated animals is explicable on the basis
of the falling Ip which was demonstrated
by the labelling studies.
Cell position
1-4
Mean±s.e.
5-8
Mean±S.e.
9-12
Mean± s.e.
13-16
Mean+S.e.
17-20
Mean±s.e.
21-24
Mean±s.e.
25+
Mean±s.e.
Whole crypt
Mean+s.e.
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TrABLE II. SummaryofApparent Cell-cycle
Times (Tc(a)) inNYormalandDMH-treated
Rats, from Analyysis of Aletaphase Ac-
cutmulation after Vincristine (Incorpor-
ating Tannock's Factor). The 9.o5 -
confidence Limiits of TC(a) of the Ithole-
crypt Data are in Parentheses
Celi position DM llH-trceate(d animals Conitrol
1-4 41 15
5 8 I 8 9
9- 12 14 8
1:--16 12 8
17 -20 11 11
21-24 11 23
25,28 14 71
29 32 14
33-36 14
:37 40 23
Whole crypt I 6-4 (118-27-2) 12 2 (10-2-15-0)
By constructing cumulative-birth-rate
curves a measure ofthe cell velocity at the
top of the crypt can be obtained (Cairnie
et al., 1965). A method has been described
by WTright et al. (1972). In Fig. 7 cumula-
tive-birth-rate curves of normal rats (data
of WN'right et al., 1975) and of the DMH-
treated animals are compared. These
curves take into account the effects of
TI'annock's factor (q.v.). An exponential
age distribution has been assumed. In the
treated animals, cell elocity at the top of
the crypt is 2-0 cell positions per hour,
whereas in normals this value is 1 6/h.
Thus we can conclude that the elongated
abnormal crypts of the carcinogen-treated
animals are producing a greater number of
progeny than normal crypts. A comparison
of the slope of the cumulative-birth-rate
cuLrves, however, shows that within the
proliferative compartment the normal
rises more steeply than the abnormal.
Once again this effect appears to be a
manifestation of a lower growth fraction
within the proliferative compartment.
1)ISCUSSION
C'rypt hyperplasia
These results show that duiring DMH
treatment of rats crypt hyperplasia occurs
in the proximal small bowrel. There aire
apparentlv 2 separ<ate phases: initially a
sustained modest elongation is seen from
control levels of about 34 cells to 36-40
cells; and after about 24 weeks of treat-
ment a sudden, much more dramatic
elongation to 43-63 cells is seen. This
latter increase in crypt length coincides
with the development, in an increasingly
large proportion of animals, of foci of
atypia and of frank malignantneoplasms
largely localized to the region under study.
Tlhis crypt hyperplasia is not explicable
simply onthebasisofageing (Clarke, 1977),
and it is tempting to speculate that it
represents a preneoplastic phase.
Nevertheless, hyperplasia of small-
intestinal crypts has been described in a
variety of circumstances not obviously
related to the development of neoplastic
disease. Cairnie and Bentley (1967) de-
scribed crypt hyperplasia as a normal
physiological event during lactation. They
found an increase in column count also,
and a suggestion of increased migration
rates; growth fraction remained uin-
changed.
As regards pathological states, gluten-
sensitive enteropathy in man is character-
ized by crypt hyperplasia, associated with
an increased rate ofcell migration from the
crypts (Wright et al., 1973). It was con-
sidered on the basis of mitotic-index-
distribution analysis that the growth
fraction was slightly lower in coeliac
patients than in controls, and there was
good evidence of a shortening of the cell-
cycle time in the proliferative compart-
ment. Various workers have produced
models ofcrypt hyperplasia in experiment-
al animals. AW'hen rat jejunum is explanted
to the skin surface a state of crYpt hyper-
plastic villous atrophyT results, with a
greatly increased rate of migration of cells
on to the surface of the mucosa (Loehrv
and Grace, 1974). Crypt hyperplasia has
been described in rats infested with the
nematode Nippostrongylus brasiliensis
(Symons, 1965). Once again the migra-
tion rate of cells out of the crypts seemed
to be enhanced. These conditions of crypt
hyperplasia appear to represent a responise
to some irritanit or inflamnmatory process
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entiated epithelium within the crypts.
Mucosal hyperplasias have also been
described in the colon of experimental
animals during DMH carcinogenesis
(Wliebecke et al., 1973; Tutton and Barkla,
1976). In the latter authors' experience,
increase in the circumference ofthe crypts
was more prominent than elongation.
nafterVcr. Growthfraction
* From the form of the labelling-index
distribution curves it is quite obvious that
, in the DMH-treated animals there is a
,' a * considerable increase in the absolute size
- ' - -ofthe so-called proliferative compartment.
,,' / - However, the ratio of the site with 50%0
of the peak labelling to the total crypt
-S' / ,S,-' height in fact falls from 0-59 in control
animals to 0-56 in treated animals. This
* ,S' small change is probably not significant.
Considering the ratio of observed label-
ling index to theoretical labelling index
(derived from FLM curves), we find an Ip
60 80 100 110 estimate for the whole crypt of about 049
afe Vcr.
1 120in DMH-treated animals, which is sub- Fin) after Vcr. stantially less than the value of 0-67
calculated using data from normal animals
from the same colony. This we consider
,- - reliable evidence that the growth fraction
, - - falls in the hyperplastic crypts of DMH-
,,'0 / treated animals. Furthermore there is the
,,- ':/ ,,' strong suggestion that much of this
.-' ,,v' reduction in proliferating population is
-,,*' occurring within the so-called proliferative
compartment, and may be due to the
alkylating properties of metabolites of
l DMH (Pozharisski et al., 1975). There is,
so 80 100 120 however, no histological evidence of cell
after Vcr.
Fia. 6. Examples of accumulation of mitosis
after vincristine (Ver.) administration: (a)
Cell Position 1-4, (b) 9-12, (c) pooled whole
crypt. The dotted lines indicate the 95%0 confilence limits for the fittecl lines.
causing an increased rate ofloss of mature
cells from the mucosal surface.
Wiebecke et al. (1973) described "more
or less localised mucosal hyperplasias"
occurring in the small bowel of DMH-
treated rats, and mentioned the presence
of sharply demarcated zones of undiffer-
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FIG. 7. Cumulative birth-rate curves: (a)
normal animals, (b) DMH-treated grotup.
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damage or death. It is of interest to note
that Loehry and Grace (1974) suspected a
similar type of change, on the basis of
simple labelling studies in their model.
Wright and colleagues (1973) showed a fall
in Ip in coeliac patients, while in lactating
rats, Cairnie and Bentley (1967) thought
Ip to be unchanged.
Cellproliferation
The results ofthe FLM experiment show
that actual cell-cycle times remain more or
less unchanged in treated animals. The
small standard errors generated by the
Gilbert programme are, we feel, a consider-
able underestimate in this situation. In the
vincristine experiment a similar prolonga-
tion in Tc(a) is seen to that noted by
Tutton and Barkla (1976) in the colonic
crypts of DMH-treated rats; Tc(a) at
virtually all sites is somewhat prolonged,
and this is explicable on the basis of the
fall in Ip. Cell-cycle times have seldom
been estimated in other mucosal hyper-
plasias: in Nippostrongylus infestation,
however, Symons (1965) found a fairly
convincing reduction in Tc using an FLM
method, and Wright et al. (1973) found
suggestive evidence of a fall in Tc(a) in
human coeliac mucosa.
In all the hyperplasias described in the
reports cited, an increase in cell production
rate has been described or inferred. The
results of the present work show a modest
increase in the rate of movement of cells
from the top of the crypt with a value of
2-0 cell positions/h in DMH-treated ani-
mals and 1 6 cell positions/h in controls.
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